Botulinum toxin type A injection for the management of myofascial temporomandibular pain disorder

Asian Journal of Oral and Maxillofacial Surgery

Volumn 17, Issue 2, 2005, Pages 100-103

  Lee, Kin Man ^a,b   Chow, James ^a   Hui, Edward ^a   Li, William ^a  

^a Tideman Maxillofacial Centre   (Hong Kong)

^b The Centre   (Hong Kong)

Author keywords

Botulinum toxin type A; Myofascial pain syndromes; Temporomandibular joint disorders

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MALE; MYOFASCIAL PAIN; PILOT STUDY; PROSPECTIVE STUDY; QUESTIONNAIRE; REMISSION; SIDE EFFECT; SYMPTOM; TEMPOROMANDIBULAR JOINT DISORDER; TREATMENT OUTCOME;

EID: 22844434666     PISSN: 09156992     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0915-6992(05)80032-9     Document Type: Article

References (12)

1. Gray RJM, Davies SJ, Quayle AA. A clinical approach to temporomandibular disorders. 1. Classification and functional anatomy. Br Dent J 1994;176:429-435.
2. Manfredini D, Bandettini di Poggio A, Cantini E, Dell'Osso L, Bosco M. Mood and anxiety psychopathology and temporomandibular disorder: a spectrum approach. J Oral Rehabil 2004;31:933-940.
3. Manfredini D, Landi N, Bandettini Di Poggio A, Dell'Osso L, Bosco M. A critical review on the importance of psychological factors in temporomandibular disorders. Minerva Stomatol 2003;52:321-326, 327-330.
4. Castro WH, Santiago Gomez R, da Silva Oliveira J, Gontijo Moura MD, Santiago Gomez R. Botulinum toxin type A in the management of masseter muscle hypertrophy. J Oral Maxillofac Surg 2005;63:20-24.
5. Lang AM. Botulinum toxin therapy for myofascial pain disorders. Curr Pain Headache Rep 2002;6:355-360.
6. Lang AM. A pilot study of botulinum toxin type A (Botox), administered using a novel injection technique, for the treatment of myofascial pain. Am J Pain Manage 2000;10:108-112.
7. Cheshire WP, Abashian SW, Mann JD. Botulinum toxin in the treatment of myofascial pain syndrome. Pain 1994;59:65-69.
8. Farella M, Michelotti A, Gargano A, Cimino R, Ramaglia L. Myofascial pain syndrome misdiagnosed as odontogenic pain: a case report. Cranio 2002;20:307-311.
9. Velly AM, Gornitsky M, Philippe P. Contributing factors to chronic myofascial pain: a case-control study. Pain 2003;104:491-499.
10. Ekberg E, Vallon D, Nilner M. The efficacy of appliance therapy in patients with temporomandibular disorders of mainly myogenous origin. A randomized, controlled, short-term trial. J Orofac Pain 2003;17:133-139.
11. Raphael KG, Klausner JJ, Nayak S, Marbach JJ. Complementary and alternative therapy use by patients with myofascial temporomandibular disorders. J Orofac Pain 2003;17:36-41.
12. Israel HA, Ward JD, Horrell B, Scrivani SJ. Oral and maxillofacial surgery in patients with chronic orofacial pain. J Oral Maxillofac Surg 2003;61:662-667.